T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2 + prostate and breast cancer cells
Open Access
- 10 September 2012
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 109 (39) , 15877-15881
Abstract
To produce genetically engineered T cells directed against prostate and breast cancer cells, we have cloned the T-cell receptor recognizing the HLA-A2–restricted T-cell recptor γ-chain alternate reading-frame protein (TARP) 4–13 epitope. TARP is a protein exclusively expressed in normal prostate epithelium and in adenocarcinomas of the prostate and breast. Peripheral blood T cells transduced with a lentiviral vector encoding the TARP-TCR proliferated well when exposed to peptide-specific stimuli. These cells exerted peptide-specific IFN-γ production and cytotoxic activity. Importantly, HLA-A2 + prostate and breast cancer cells expressing TARP were also killed, demonstrating that the TARP 4–13 epitope is a physiologically relevant target for T-cell therapy of prostate and breast cancer. In conclusion, we present the cloning of a T cell receptor (TCR) directed against a physiologically relevant HLA-A2 epitope of TARP. To our knowledge this report on engineering of T cells with a TCR directed against an antigen specifically expressed by prostate cells is unique.Keywords
This publication has 21 references indexed in Scilit:
- Development of Novel Immune Interventions for Prostate CancerClinical Genitourinary Cancer, 2012
- Recognition of Prostate and Breast Tumor Cells by Helper T Lymphocytes Specific for a Prostate and Breast Tumor-Associated Antigen, TARPClinical Cancer Research, 2005
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004
- Human CTLs to Wild-Type and Enhanced Epitopes of a Novel Prostate and Breast Tumor-Associated Protein, TARP, Lyse Human Breast Cancer CellsCancer Research, 2004
- Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARPThe Prostate, 2004
- Ex vivo stimulation of cytomegalovirus (CMV)‐specific T cells using CMV pp65‐modified dendritic cells as stimulatorsBritish Journal of Haematology, 2003
- High expression of a specific T-cell receptor γ transcript in epithelial cells of the prostateProceedings of the National Academy of Sciences, 1999
- Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Membrane AntigenNeoplasia, 1999
- Molecular Characterization of Defective Antigen Processing in Human Prostate CancerJNCI: Journal of the National Cancer Institute, 1995
- Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAsNucleic Acids Research, 1984